Myriad sues competitors for infringing genes patents

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Myriad sues competitors for infringing genes patents

Myriad is suing two competitors for allegedly infringing its patents on genes that can help to detect cancer, despite a ruling by the Supreme Court that human genes are ineligible for patent protection

myriad.jpg

In Association for Molecular Pathology v Myriad Genetics last month, the court ruled that isolated and purified DNA was a product of nature, which is exempt from patent protection under Section 101. The justices ruled that complementary DNA (cDNA) can be patented, however, because it requires significant human skill to create.

The genes could be used to screen for breast and ovarian cancer, but because Myriad owns the patents on them, other companies were unable to offer the tests. Utah-based Myriad charged around $3,000 for providing testing for the two genes.

Since the ruling, companies and universities have announced they will provide the tests. Last week, Myriad sued two of these companies, Ambry Genetics and Gene by Gene, claiming their tests infringed other patents owned by Myriad that were not invalidated by the court.

In a statement, Ambry CEO Charles Dunlop said the company will “vigorously defend” the complaint and the motion for preliminary injunction. He said the company has had “an overwhelming response from our clients seeking an alternative laboratory to perform BRCA testing”.

Myriad has filed a separate complaint against Gene by Gene.

more from across site and SHARED ros bottom lb

More from across our site

Europe is among the easier and most lucrative legal markets for PE firms to bet on, but clients’ reaction will decide whether external investment drives success
Rulings of note covered pre-June 2023 infringements and jurisdiction over non-UPC states, while winners of Managing IP’s EMEA Awards acted in multiple cases
Jason Blair, a former special marks examiner, said Dykema’s Texas presence will help him build deeper connections with clients
Lee Curtis and Rachel Platts at HGF discuss the rise of the ‘intention economy’ and its impact on trademark law
Martin Wintermeier discusses taking a hit for clients, not letting stress get to you, and why being a criminal defence lawyer might have been fun
Exclusive data and analysis reveal why clients feel external legal teams aren’t providing business-centric advice
The head of the soft IP team at engineering group Sandvik, winner of the in-house team of the year award, reveals why a flurry of M&A activity led to a busy 2024
Lawyers at Herbert Smith Freehills outline what rights owners should be doing ahead of sweeping changes to EU design law
Deals between five more law firms and President Trump and an antitrust lawsuit against Amgen were also among the top talking points this week
US counsel explain how they win new cleantech IP business and how they’re navigating the industry’s challenges
Gift this article